Charcot–Marie–Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death
Journal of Cell Science · 2025
DOI: 10.1242/jcs.263691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Science, 2025. Verfasst von Mariana Joaquim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Genetics, University of Cologne, 50674 Cologne, Germany. Hauptthemen laut MEDLINE: Apoptosis, Charcot-Marie-Tooth Disease, GTP Phosphohydrolases, Mitochondrial Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for Molecular Medicine Cologne (CMMC), Fritz Thyssen Foundation, Boehringer Ingelheim Foundation.
Abstract (Originalsprache)
The neuropathy Charcot–Marie–Tooth (CMT) is an incurable disease with a lack of genotype–phenotype correlation. Variants of the mitochondrial protein mitofusin 2 (MFN2), a large GTPase that mediates mitochondrial fusion, are responsible for the subtype CMT type 2A (CMT2A). Interestingly, beyond membrane remodelling, additional roles of MFN2 have been identified, expanding the possibilities to explore its involvement in disease. Here, we investigated how cellular functions of MFN2 are associated with variants present in individuals with CMT2A. Using human cellular models, we observed that cells expressing CMT2A variants display increased endoplasmic reticulum (ER) stress and apoptotic cell death. Increased cleavage of PARP1, caspase 9, caspase 7 and caspase 3, alongside BAX translocation to mitochondria, pointed towards effects on intrinsic apoptosis. Moreover, although disruption of fusion and fission dynamics per se did not correlate with cell death markers, expression of MFN1 or MFN2 alleviated the apoptosis markers of CMT2A variant cell lines. In sum, our results highlight excessive cell death by intrinsic apoptosis as a potential target in CMT2A disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Genetics, University of Cologne, 50674 Cologne, Germany.
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany.
- Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.
- Institute of Pathology, Medical Faculty and University Hospital, University of Cologne, 50937 Cologne, Germany.
- University of Angers, MitoLab Team, MitoVasc Unit, CNRS UMR6015, INSERM U1083, Structure Fédérative de Recherche (SFR), Interactions Cellulaires et Applications Thérapeutiques (ICAT), 49330, Angers, France.
- Comparative Medicine, Center for Molecular Medicine Cologne (CMMC), Medical Faculty and University Hospital, University of Cologne, 50931 Cologne, Germany.
ORCID-Profile: Mafalda Escobar-Henriques
Förderung
- Center for Molecular Medicine Cologne (CMMC)
- Fritz Thyssen Foundation
- Boehringer Ingelheim Foundation
- Deutsche Forschungsgemeinschaft
- Bayer Foundation
- University of Cologne
Zitieren
APA
Joaquim, M., Bulimaga, M. B., Mohn, M. A., Plouzennec, S., Osinski, L., Altin, S., Mahabir, E., Chevrollier, A., & Escobar-Henriques, M. (2025). Charcot–Marie–Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death. Journal of Cell Science. https://doi.org/10.1242/jcs.263691
Vancouver
Joaquim M, Bulimaga MB, Mohn MA, Plouzennec S, Osinski L, Altin S, et al. Charcot–Marie–Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death. Journal of Cell Science. 2025. doi:10.1242/jcs.263691
BibTeX
@article{Joaquim2025,
author = {Joaquim, Mariana and Bulimaga, Maria-Bianca and Mohn, Marie A and Plouzennec, Solenn and Osinski, Leon and Altin, Selver and Mahabir, Esther and Chevrollier, Arnaud and Escobar-Henriques, Mafalda},
title = {Charcot–Marie–Tooth type 2A variants of mitofusin 2 sensitize cells to apoptotic cell death},
journal = {Journal of Cell Science},
year = {2025},
doi = {10.1242/jcs.263691}
}
EUVIMED